Work

The Role of Psychostimulants in the Management of Refractory Catatonia: A Comprehensive Review of Case Reports

Year: 2026
Type: article
Abstract: Background/Objectives: Catatonia is a neuropsychiatric syndrome characterised by motor, behavioural, and affective abnormalities and is frequently associated with mood disorders, particularly major depressive and bipolar disorders. Although benzodiazepines and electroconvulsive therapy are considered first-line treatments, a substantial proportion of patients show partial or no response, especially in chronic, affective, or medically complex presentations. Contemporary neurobiological models implicate dysfunction across multiple neurotransmitter systems, including GABAergic, glutamatergic, and dopaminergic pathways, as well as disturbances in cortico-striato-thalamo-cortical circuits involved in psychomotor control and arousal regulation. Within this framework, psychostimulants may exert therapeutic effects by enhancing dopaminergic and noradrenergic transmission, thereby modulating frontal–striatal networks and facilitating behavioural activation and motor initiation. Evidence from conditions characterised by psychomotor slowing, apathy, and impaired behavioural initiation provides a neurophysiological rationale for their adjunctive use in selected cases of catatonia, particularly when associated with mood disorders. However, there is a dearth of empirical data, with the evidence largely confined to case reports, hence the need for comprehensive reviews of cases and controlled studies to clarify the role of psychostimulants and to explore drug combinations in the treatment of catatonia. Methods: We conducted a comprehensive review of case reports on 22 October 2026 on PubMed, Scopus, PsycInfo/PsycArticles, and Web of Science. Results: We included 9 studies. Psychostimulants were usually helpful in inducing rapid symptoms resolution of catatonia. Conclusions: Psychostimulants may be used in cases of catatonia and provide rapid improvement. Future longitudinal, double-blind designs are likely to allow reliably assessing the value of psychostimulants in catatonia.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7142096612
FWCI:
Cites: 52
Cited by:
Related to: 10